StoneRidge PMG Advisors, LLC’s Biogen BIIB Stock Holding History

StoneRidge PMG Advisors, LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$701K	Buy	+3,104	New	+$658K	0.49%	50

Other funds holding BIIB

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

StoneRidge PMG Advisors, LLC's BIIB Position: Q3 2026 in Review

StoneRidge PMG Advisors, LLC opened a new position in Biogen (BIIB) in Q3 2026: 3,104 shares worth $701K. The stake represents 0.49% of the portfolio and ranks #50 among its holdings.

467 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

StoneRidge PMG Advisors, LLC held 3,104 shares of Biogen worth $701K as of Q3 2026.
Biogen was a new StoneRidge PMG Advisors, LLC position in Q3 2026.
Biogen made up 0.49% of StoneRidge PMG Advisors, LLC's portfolio in Q3 2026, its #50 holding.
467 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.